Stockholders reject advisory say-on-pay proposal at Castle Biosciences annual meeting

CASTLE BIOSCIENCES INC

Say-on-pay failed: 8,331,458 For vs 11,985,739 Against; broker non-votes 1,869,015.
Class III directors Kimberlee S. Caple, G. Bradley Cole, and Derek J. Maetzold re-elected.
Ratified KPMG LLP as independent auditor for fiscal year 2022 (22,499,340 For).
Advisory vote on frequency: 20,368,320 preferred 1 year; board will hold annual say-on-pay votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.